SS Innovations International, the developer of India’s first indigenous surgical robotic system, marked a major milestone by ringing the opening bell at the Nasdaq MarketSite in New York City. The event, led by Dr. Sudhir Srivastava—Founder, Chairman, and CEO—celebrates the company’s listing under the ticker symbol SSII and highlights India’s growing impact on global medical technology.

The company’s flagship innovation, the SSI Mantra Surgical Robotic System, has already been deployed in 80 hospitals across 75 Indian locations and several international markets, including Nepal, Ecuador, the Philippines, and Colombia. With over 4,000 robotic procedures completed across 100+ surgical types and no recorded complications or fatalities, the system is transforming access to advanced surgical care through cost-effective technology.

As SS Innovations expands into Europe and the U.S., it continues to strengthen India's presence in the high-tech medical arena. The company recently reported substantial growth, with 2024 revenues reaching $20.6 million—more than triple the previous year’s $5.9 million—and gross margins increasing from 12.3% to 40.9%.

Dr. Srivastava emphasized the significance of the Nasdaq bell ceremony, calling it a proud moment that celebrates the team’s hard work and the potential of Indian innovation in global healthcare. With a mission to democratize access to robotic surgery, SS Innovations is poised to become a global leader while placing India at the center of medical tech advancement.